Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · June 29, 2022

TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma

Journal of Thoracic Oncology

 

Additional Info

Journal of Thoracic Oncology
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma
J Thorac Oncol 2022 Jun 01;17(6)779-792, NI Vokes, E Chambers, T Nguyen, A Coolidge, CA Lydon, X Le, L Sholl, JV Heymach, M Nishino, EM Van Allen, PA Jänne

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading